Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Searching Images

normal ECG waves P QRS T intervals leads diagram

A standard 12-lead electrocardiogram (ECG) displayed on a red grid background, demonstrating normal sinus rhythm at a rate of approximately 70 beats per minute. The tracing includes limb leads (I, II, III), augmented limb leads (aVR, aVL, aVF), precordial leads (V1-V6), and a continuous rhythm strip of lead II at the bottom. The QRS complexes exhibit normal duration and morphology without pathological widening. P waves are identifiable before each QRS complex, indicating atrial depolarization originating from the sinoatrial node. T waves are upright in leads I, II, aVF, and V2-V6, and appropriately inverted in lead aVR. There is a lack of acute ST-segment elevation or depression. The R-R intervals are regular, reflecting a stable cardiac rhythm. This tracing represents the resolution of previously identified junctional bradycardia following the treatment of hyperkalemia. The technical parameters are visible at the bottom, indicating a standard paper speed of 25 mm/sec and voltage calibration of 10 mm/mV.

A standard 12-lead electrocardiogram (ECG) displayed on a red grid background, demonstrating normal sinus rhythm at a rate of approximately 70 beats per minute. The tracing includes limb leads (I, II, III), augmented limb leads (aVR, aVL, aVF), precordial leads (V1-V6), and a continuous rhythm strip of lead II at the bottom. The QRS complexes exhibit normal duration and morphology without pathological widening. P waves are identifiable before each QRS complex, indicating atrial depolarization originating from the sinoatrial node. T waves are upright in leads I, II, aVF, and V2-V6, and appropriately inverted in lead aVR. There is a lack of acute ST-segment elevation or depression. The R-R intervals are regular, reflecting a stable cardiac rhythm. This tracing represents the resolution of previously identified junctional bradycardia following the treatment of hyperkalemia. The technical parameters are visible at the bottom, indicating a standard paper speed of 25 mm/sec and voltage calibration of 10 mm/mV.

A standard 12-lead electrocardiogram (ECG) displayed on a traditional red grid background. The tracing shows a normal sinus rhythm with a regular rate and consistent R-R intervals. P waves are clearly visible preceding each QRS complex in the limb and precordial leads. The QRS complexes are of normal duration and morphology, with a standard R-wave progression observed from V1 through V6. The ST segments appear isoelectric without clear evidence of acute ST-elevation or depression in any lead. T waves are upright in most leads, with the exception of lead V1 and aVR, where inversion is a normal variant. This ECG represents a clinically stable cardiac state at the time of presentation, despite the patient's underlying severe coronary artery disease (CAD), including significant stenosis of the left anterior descending and left circumflex arteries. The absence of acute ischemic changes or pathological Q waves highlights that baseline ECGs can remain unremarkable even in the presence of severe structural heart disease.

A standard 12-lead electrocardiogram (ECG) displayed on a traditional red grid background. The tracing shows a normal sinus rhythm with a regular rate and consistent R-R intervals. P waves are clearly visible preceding each QRS complex in the limb and precordial leads. The QRS complexes are of normal duration and morphology, with a standard R-wave progression observed from V1 through V6. The ST segments appear isoelectric without clear evidence of acute ST-elevation or depression in any lead. T waves are upright in most leads, with the exception of lead V1 and aVR, where inversion is a normal variant. This ECG represents a clinically stable cardiac state at the time of presentation, despite the patient's underlying severe coronary artery disease (CAD), including significant stenosis of the left anterior descending and left circumflex arteries. The absence of acute ischemic changes or pathological Q waves highlights that baseline ECGs can remain unremarkable even in the presence of severe structural heart disease.

A standard 12-lead electrocardiogram (ECG) displayed on a traditional pink grid background. The tracing demonstrates a normal sinus rhythm characterized by a regular ventricular rate and consistent R-R intervals. Distinct P waves precede every QRS complex, particularly visible as upright deflections in leads II, III, aVF, and V2 through V6. The QRS complexes exhibit normal morphology and duration without evidence of widening or bundle branch blocks. The ST segments are isoelectric throughout all limb and precordial leads, indicating an absence of acute ST-elevation myocardial infarction (STEMI) or significant ST-depression suggestive of ischemia. T waves are generally upright and symmetrical across the precordium. The tracing includes a rhythm strip at the bottom (leads V1, II, and V5) for continuous assessment of the cardiac cycle. This diagnostic image represents a baseline cardiac evaluation for a patient presenting with syncope and hypovolemic shock, providing a clinical comparison for later episodes of potential coronary vasospasm.

A standard 12-lead electrocardiogram (ECG) displayed on a traditional pink grid background. The tracing demonstrates a normal sinus rhythm characterized by a regular ventricular rate and consistent R-R intervals. Distinct P waves precede every QRS complex, particularly visible as upright deflections in leads II, III, aVF, and V2 through V6. The QRS complexes exhibit normal morphology and duration without evidence of widening or bundle branch blocks. The ST segments are isoelectric throughout all limb and precordial leads, indicating an absence of acute ST-elevation myocardial infarction (STEMI) or significant ST-depression suggestive of ischemia. T waves are generally upright and symmetrical across the precordium. The tracing includes a rhythm strip at the bottom (leads V1, II, and V5) for continuous assessment of the cardiac cycle. This diagnostic image represents a baseline cardiac evaluation for a patient presenting with syncope and hypovolemic shock, providing a clinical comparison for later episodes of potential coronary vasospasm.

Searching Images

oxygen hemoglobin dissociation curve sigmoid shape

Summary : This figure illustrates the relationship between hemoglobin (Hb) level and oxygen delivery in individuals with sickle cell disease (SCD), highlighting the optimal Hb range for oxygen transport in SCD compared to normal individuals.

line plot:
# Title & Axes :
  • No explicit title on the plot, but the context is "Relationship between hemoglobin level and oxygen delivery in individuals with SCD."
  • X-axis: "Hemoglobin" (units not specified, but contextually g/dL).
  • Y-axis: "Oxygen delivery" (units not specified).
  • X-axis tick labels: 10, 15, 20.
  • Y-axis: No tick labels, only qualitative trend.

# Data Points & Series :
  • Single red curve showing oxygen delivery as a function of hemoglobin level.
  • The curve rises from Hb = 10, peaks near Hb = 14–16, then declines toward Hb = 20.
  • Arrow and annotation for "Sickle Cell Anemia Hb_max ~10–11" indicating the optimal Hb range for SCD.
  • Dashed vertical line at "Normal Hb_max ~14–16" indicating the optimal Hb range for normal individuals.

# Design Encodings :
  • Red solid line for the main curve.
  • Yellow arrow highlighting the SCD optimal Hb range.
  • Dashed vertical line for normal Hb_max.
  • Text annotations for "Sickle Cell Anemia Hb_max ~10–11" and "Normal Hb_max ~14–16".

# Distribution & Trends :
  • The curve is unimodal, peaking at intermediate Hb levels.
  • Oxygen delivery increases with Hb up to a point, then decreases at higher Hb levels.
  • The optimal Hb for SCD is lower (~10–11 g/dL) than for normal individuals (~14–16 g/dL).

# Analysis :
  • The figure visually demonstrates that the maximal oxygen delivery in SCD occurs at a lower hemoglobin level than in normal individuals, due to altered red cell viscosity and oxygen transport in SCD.
  • Increasing Hb above the SCD optimal range may decrease oxygen delivery, while lowering Hb to the optimal range can improve oxygen transport.
  • The curve supports clinical recommendations for transfusion targets in SCD patients to avoid excessive Hb levels that could impair oxygen delivery.

Summary : This figure illustrates the relationship between hemoglobin (Hb) level and oxygen delivery in individuals with sickle cell disease (SCD), highlighting the optimal Hb range for oxygen transport in SCD compared to normal individuals. line plot: # Title & Axes : • No explicit title on the plot, but the context is "Relationship between hemoglobin level and oxygen delivery in individuals with SCD." • X-axis: "Hemoglobin" (units not specified, but contextually g/dL). • Y-axis: "Oxygen delivery" (units not specified). • X-axis tick labels: 10, 15, 20. • Y-axis: No tick labels, only qualitative trend. # Data Points & Series : • Single red curve showing oxygen delivery as a function of hemoglobin level. • The curve rises from Hb = 10, peaks near Hb = 14–16, then declines toward Hb = 20. • Arrow and annotation for "Sickle Cell Anemia Hb_max ~10–11" indicating the optimal Hb range for SCD. • Dashed vertical line at "Normal Hb_max ~14–16" indicating the optimal Hb range for normal individuals. # Design Encodings : • Red solid line for the main curve. • Yellow arrow highlighting the SCD optimal Hb range. • Dashed vertical line for normal Hb_max. • Text annotations for "Sickle Cell Anemia Hb_max ~10–11" and "Normal Hb_max ~14–16". # Distribution & Trends : • The curve is unimodal, peaking at intermediate Hb levels. • Oxygen delivery increases with Hb up to a point, then decreases at higher Hb levels. • The optimal Hb for SCD is lower (~10–11 g/dL) than for normal individuals (~14–16 g/dL). # Analysis : • The figure visually demonstrates that the maximal oxygen delivery in SCD occurs at a lower hemoglobin level than in normal individuals, due to altered red cell viscosity and oxygen transport in SCD. • Increasing Hb above the SCD optimal range may decrease oxygen delivery, while lowering Hb to the optimal range can improve oxygen transport. • The curve supports clinical recommendations for transfusion targets in SCD patients to avoid excessive Hb levels that could impair oxygen delivery.

This diagnostic image set displays two functional MR images (A and B) showing maternal-fetal units in a mouse model at embryonic days 14.5 and 17.5. The images feature overlaid color-coded AP50 maps, which represent fetal and placental oxygen-hemoglobin dissociation parameters. In both panels, the placenta and fetal liver are isolated as regions of interest. A vertical color bar on the right side indicates AP50 values scaled from 0 to 1.0, with cool colors (dark blue) representing lower values and warm colors (red/orange) representing higher values. Panel A (day 14.5) demonstrates a heterogeneous distribution of oxygenation parameters within the tissues, showing a mix of green, yellow, and blue pixels. Panel B (day 17.5) illustrates the progression of these physiological markers over time, with the placental AP50 values showing a significant spatial shift toward warmer colors, reflecting changes in oxygen transfer efficiency. These maps provide a non-invasive visual method for studying fetal oxygenation and placental function during gestation.

This diagnostic image set displays two functional MR images (A and B) showing maternal-fetal units in a mouse model at embryonic days 14.5 and 17.5. The images feature overlaid color-coded AP50 maps, which represent fetal and placental oxygen-hemoglobin dissociation parameters. In both panels, the placenta and fetal liver are isolated as regions of interest. A vertical color bar on the right side indicates AP50 values scaled from 0 to 1.0, with cool colors (dark blue) representing lower values and warm colors (red/orange) representing higher values. Panel A (day 14.5) demonstrates a heterogeneous distribution of oxygenation parameters within the tissues, showing a mix of green, yellow, and blue pixels. Panel B (day 17.5) illustrates the progression of these physiological markers over time, with the placental AP50 values showing a significant spatial shift toward warmer colors, reflecting changes in oxygen transfer efficiency. These maps provide a non-invasive visual method for studying fetal oxygenation and placental function during gestation.

Here are complete, exam-ready answers for all 17 questions from your KIMS Physiology Paper 1:

KIMS - Department of Physiology | Paper 1 - Third Internal Assessment

Complete Answer Guide


LONG ESSAY (10 marks)

Q1. Describe the leads, waves and intervals of normal ECG. Mention the ECG changes in cardiac infarction.

A. LEADS OF ECG (12 leads total)

Limb Leads (Standard / Bipolar):
  • Lead I: Right arm (-) to Left arm (+)
  • Lead II: Right arm (-) to Left leg (+)
  • Lead III: Left arm (-) to Left leg (+)
Augmented Unipolar Limb Leads:
  • aVR: Right arm
  • aVL: Left arm
  • aVF: Left foot
Precordial / Chest Leads (V1 - V6):
  • V1: 4th intercostal space, right sternal border
  • V2: 4th intercostal space, left sternal border
  • V3: Between V2 and V4
  • V4: 5th intercostal space, mid-clavicular line
  • V5: Anterior axillary line (same horizontal level as V4)
  • V6: Mid-axillary line (same horizontal level as V4-V5)

B. WAVES OF NORMAL ECG

WaveOriginDurationAmplitude
P waveAtrial depolarization (SA node → atria)0.08-0.1 s<2.5 mm
QRS complexVentricular depolarization0.06-0.10 sVariable
T waveVentricular repolarization0.16-0.27 sUpright in most leads
U wavePurkinje fiber repolarization (not always seen)-Small, after T
QRS components:
  • Q wave: First downward deflection (septal depolarization)
  • R wave: First upward deflection
  • S wave: Downward deflection after R

C. INTERVALS AND SEGMENTS

Interval/SegmentNormal DurationSignificance
PR interval0.12 - 0.20 sAV conduction time
QRS duration0.06 - 0.10 sVentricular depolarization
QT interval0.35 - 0.44 sVentricular depolarization + repolarization
ST segmentIsoelectricPlateau phase of ventricular AP
PR segmentIsoelectricAV nodal delay
Paper speed: 25 mm/sec | 1 small square = 0.04 sec | 1 large square = 0.20 sec

D. ECG CHANGES IN MYOCARDIAL INFARCTION

ECG changes in MI follow a sequence based on the time elapsed:
Hyperacute (minutes to hours):
  • Tall, peaked (hyperacute) T waves - earliest change
  • ST segment elevation (> 1 mm in limb leads, > 2 mm in chest leads)
Acute (hours to days):
  • ST elevation (STEMI pattern - "tombstone" or convex upward)
  • Development of pathological Q waves (>0.04 s duration, >25% of R wave height)
  • T wave inversion begins
Subacute (days to weeks):
  • Pathological Q waves persist
  • ST returns toward baseline
  • Deep, symmetric T wave inversion (Wellens' sign pattern)
Old/Chronic (weeks to months):
  • Persistent pathological Q waves (permanent scar)
  • ST normalizes
  • T waves may normalize or remain inverted
Localizing the infarct by leads:
TerritoryLeads showing changesArtery
AnteriorV1-V4LAD
LateralI, aVL, V5-V6LCx
InferiorII, III, aVFRCA
PosteriorTall R in V1-V2 (reciprocal)RCA/LCx
Here is a normal 12-lead ECG for reference:
Normal 12-lead ECG

SHORT ANSWERS (3 marks each)

Q2. Explain why normally blood does not clot in vivo.

Blood remains fluid in the living body due to multiple natural anticoagulant mechanisms:
  1. Smoothness of vascular endothelium: Intact endothelium does not activate factor XII (Hageman factor) - no trigger for intrinsic pathway.
  2. Prostacyclin (PGI2): Released by endothelial cells; inhibits platelet aggregation and promotes vasodilation.
  3. Antithrombin III (heparin cofactor): Neutralizes thrombin and several other activated clotting factors (Xa, IXa, XIa).
  4. Thrombomodulin: Endothelial protein that binds thrombin; the complex activates Protein C.
  5. Protein C and Protein S: Together inactivate Factor Va and Factor VIIIa.
  6. Tissue Factor Pathway Inhibitor (TFPI): Inhibits the extrinsic pathway (Factor VIIa-tissue factor complex).
  7. Natural heparin: Released by mast cells and basophils; enhances antithrombin III activity.
  8. Fibrinolytic system (plasmin): Dissolves any small clots that form.
  9. Blood flow: Continuously dilutes and removes activated clotting factors.

Q3. Explain why cardiac muscle cannot be tetanised.

Cardiac muscle cannot be tetanised because of its prolonged refractory period, which is a unique property compared to skeletal muscle.
Mechanism:
  • The cardiac action potential lasts approximately 200-400 ms (compared to 1-2 ms in skeletal muscle).
  • The absolute refractory period (ARP) of cardiac muscle lasts almost as long as the action potential itself - about 200-250 ms.
  • This is due to the prolonged plateau phase (Phase 2) maintained by slow L-type Ca²+ channels remaining open.
Why this prevents tetanus:
  • In skeletal muscle, the action potential is very short (1-2 ms), and tetanic contractions occur when stimuli arrive before relaxation is complete.
  • In cardiac muscle, no new action potential can be generated during the absolute refractory period - so no second stimulus can cause sustained contraction during the contraction phase.
  • By the time the ARP ends and the muscle is capable of responding again, the contraction is almost over and relaxation has begun.
Physiological significance: This prevents cardiac tetany, which would be fatal - the heart needs to relax between beats to allow ventricular filling (diastole).

Q4. Why is the stool bulky and pale colored in obstructive jaundice?

In obstructive (post-hepatic) jaundice, bile cannot reach the intestine due to obstruction of the bile duct (e.g., gallstones, carcinoma of head of pancreas).
Why stool is pale (clay-colored):
  • Bile salts and bilirubin cannot enter the small intestine.
  • Normally, bilirubin is converted to urobilinogen (and then to stercobilin) by gut bacteria - stercobilin gives stool its normal brown color.
  • In obstruction, no bilirubin reaches the gut, so no stercobilin is formed.
  • Result: pale, clay-colored (acholic) stools.
Why stool is bulky (steatorrhea):
  • Bile salts are essential for fat emulsification and absorption in the small intestine.
  • Without bile, dietary fats cannot be emulsified and are not absorbed by intestinal microvilli.
  • Unabsorbed fats (especially long-chain triglycerides) pass into the stool.
  • Fat in stool = steatorrhea - stool is pale, bulky, greasy, malodorous, and floats.
Additionally, fat-soluble vitamins (A, D, E, K) are not absorbed, leading to deficiency of Vitamin K - causing coagulation problems.

Q5. Explain the cause for sigmoid shape of the Oxygen-Hemoglobin Dissociation Curve.

The O2-Hb dissociation curve is sigmoid (S-shaped) due to cooperative binding (also called heme-heme interaction or allostery):
Hemoglobin structure:
  • Hb is a tetramer with 4 subunits (2α + 2β), each carrying one heme group.
  • In the deoxy state (T form / tense form), the structure is tightly folded with low O2 affinity.
Mechanism of cooperativity:
  1. When the first O2 molecule binds to one heme group, it causes a conformational change in the globin subunit.
  2. This change is transmitted to neighboring subunits via the 2,3-BPG binding site and salt bridges.
  3. The molecule shifts from T-form (tense, low affinity) → R-form (relaxed, high affinity).
  4. Each successive O2 molecule binds with increasing affinity (positive cooperativity).
  5. The 4th O2 binds with the highest affinity.
Result = Sigmoid curve:
  • At low PO2 (tissues): Hb has low affinity → readily releases O2 (flat lower portion)
  • At high PO2 (lungs): Hb has very high affinity → readily loads O2 (upper flat plateau)
  • The steep middle portion allows efficient O2 delivery over a small PO2 range (20-60 mmHg)
If Hb had only 1 subunit (like myoglobin), the curve would be hyperbolic (no cooperativity).

Q6. Explain the cause of negative resting membrane potential.

The resting membrane potential (RMP) of most cells is approximately -70 mV (inside negative relative to outside). This negativity arises from:
1. Unequal ion distribution (concentration gradients):
  • K+ is ~30x more concentrated inside the cell (140 mEq/L inside vs. 4 mEq/L outside).
  • Na+ is ~10x more concentrated outside (145 mEq/L outside vs. 10 mEq/L inside).
  • Large organic anions (proteins, phosphates) are trapped inside and cannot cross the membrane.
2. Selective membrane permeability at rest:
  • At rest, the membrane is highly permeable to K+ (via leak channels) and nearly impermeable to Na+.
  • K+ flows out down its concentration gradient, leaving behind negative charges (organic anions) inside.
  • This outward K+ current makes the inside more negative.
  • K+ continues to leave until the electrical force (pulling K+ back in) equals the chemical force (driving K+ out) = K+ equilibrium potential (~-90 mV, Nernst equation).
3. Na+-K+ ATPase pump:
  • Pumps 3 Na+ out and 2 K+ in per cycle (electrogenic).
  • Directly contributes about -5 to -10 mV to the RMP.
  • More importantly, it maintains the ion concentration gradients.
4. Gibbs-Donnan equilibrium:
  • Impermeant intracellular anions attract cations inside and repel anions, contributing to the negative interior.
Summary: RMP is mainly due to K+ diffusion potential (K+ leak channels), large intracellular anions, and the electrogenic Na+-K+ pump.

SHORT ESSAY (5 marks each)

Q7. Explain the complications of blood transfusion.

Immediate Complications:
ComplicationMechanism
Acute hemolytic reactionABO incompatibility - antibodies in recipient destroy donor RBCs; fever, chills, back pain, hemoglobinuria, renal failure, DIC
Febrile non-hemolytic reactionAntibodies against donor leukocytes/platelets; most common; fever, chills
Allergic/Anaphylactic reactionAntibodies against donor plasma proteins (esp. IgA in IgA-deficient recipients); urticaria, anaphylaxis
TRALI (Transfusion-Related Acute Lung Injury)Donor antibodies against recipient leukocytes; pulmonary edema within 6 hours
Circulatory overload (TACO)Too rapid infusion; pulmonary edema, hypertension
Air embolismAir in tubing enters vein
HypothermiaMassive transfusion with cold blood
Delayed Complications:
  • Delayed hemolytic reaction (3-14 days): Anamnestic antibody response in previously sensitized patients.
  • Alloimmunization: Development of new antibodies against donor antigens.
  • Graft-versus-host disease (GVHD): Donor lymphocytes attack immunocompromised recipient's tissues.
  • Post-transfusion purpura: Thrombocytopenia 5-10 days post-transfusion.
Metabolic Complications (massive transfusion):
  • Hypocalcemia: Citrate (preservative) chelates Ca²+.
  • Hyperkalemia: Stored blood has high K+ from hemolysis.
  • Acidosis: Citric acid + lactic acid from stored blood.
  • Coagulopathy: Dilution of clotting factors and platelets.
Transfusion-Transmitted Infections:
  • HIV, Hepatitis B, Hepatitis C, CMV, malaria, syphilis (now rare due to screening).

Q8. Define and classify shock. Explain hypovolemic shock.

Definition of Shock: Shock is a life-threatening condition of circulatory failure resulting in inadequate tissue perfusion and cellular oxygen delivery, leading to cellular dysfunction and death.
Classification:
TypeMechanismExamples
HypovolemicReduced circulating blood volumeHemorrhage, burns, dehydration, vomiting
CardiogenicPump failureMI, cardiac tamponade, severe arrhythmia
DistributiveMaldistribution of blood flowSeptic, anaphylactic, neurogenic shock
ObstructiveObstruction to blood flowPulmonary embolism, tension pneumothorax
Hypovolemic Shock - Explained:
Cause: Loss of intravascular volume (blood, plasma, or water).
Stages and Compensatory Mechanisms:
Stage I (Compensated / Up to 15% loss, <750 mL):
  • Baroreceptors detect fall in BP → sympathetic activation
  • ↑ Heart rate, ↑ Contractility
  • Vasoconstriction (arteriolar) → ↑ Peripheral resistance
  • Renin-Angiotensin-Aldosterone system activated → Na+ and water retention
  • ADH (Vasopressin) released → water reabsorption
Stage II (15-30% loss, 750-1500 mL):
  • Tachycardia, anxiety, reduced pulse pressure, prolonged capillary refill
  • Urine output decreases (20-30 mL/hr)
Stage III (30-40% loss, 1500-2000 mL):
  • Marked hypotension, tachycardia, confusion
  • Oliguria (<20 mL/hr)
Stage IV (>40% loss, >2000 mL):
  • Decompensated shock - all mechanisms fail
  • Severe hypotension, unconsciousness, anuria
  • Death if untreated
Management: Stop bleeding, IV fluids (Normal saline, Ringer's lactate), blood transfusion, vasopressors if needed.

Q9. Define Hypoxia. Explain different types of hypoxia with examples.

Definition: Hypoxia is defined as inadequate oxygen supply to tissues for normal cellular metabolic functions, despite adequate blood flow.
Types of Hypoxia:
1. Hypoxic Hypoxia (Arterial Hypoxia):
  • PaO2 is reduced; hemoglobin is not fully saturated.
  • Cause: Low inspired O2 tension (high altitude), hypoventilation (COPD, opioid overdose), diffusion impairment (pulmonary fibrosis, pneumonia), V/Q mismatch (pulmonary embolism), right-to-left shunt.
  • Example: Mountain climbers at high altitude; drowning.
2. Anemic Hypoxia:
  • PaO2 is normal but O2-carrying capacity of blood is reduced.
  • Cause: Anemia (reduced Hb), carbon monoxide poisoning (COHb), methemoglobinemia.
  • Example: CO poisoning - CO has 200x affinity for Hb over O2; patient looks "cherry red" but is hypoxic.
3. Stagnant Hypoxia (Circulatory/Ischemic Hypoxia):
  • Arterial O2 content is normal but blood flow is too slow to deliver adequate O2.
  • Cause: Heart failure, shock, local arterial obstruction.
  • Example: Congestive heart failure; gangrene of a limb.
4. Histotoxic Hypoxia:
  • O2 delivery is normal but cells cannot utilize O2 due to impaired mitochondrial function.
  • Cause: Cyanide poisoning (blocks cytochrome oxidase/Complex IV), alcohol in large doses.
  • Example: Cyanide poisoning - blood and tissues are hyperoxic, but cells cannot use the O2.
5. Demand Hypoxia (optional):
  • O2 delivery is normal but tissue demand exceeds supply.
  • Example: Extreme exercise, high fever, thyrotoxicosis.
Effects of hypoxia: Tissue damage, lactic acidosis (anaerobic glycolysis), organ dysfunction (brain most sensitive), death.

Q10. Explain pathophysiology and management of peptic ulcer.

Definition: A peptic ulcer is a mucosal break (>5 mm) in the stomach or duodenum resulting from an imbalance between aggressive and defensive factors.
Pathophysiology:
Aggressive Factors (↑ in ulcer):
  • H. pylori infection (90% of duodenal, 70% of gastric ulcers): Disrupts mucus layer, produces urease (generates NH3 → mucosal damage), stimulates gastrin release → ↑ HCl.
  • Excess HCl secretion: Stimulated by gastrin, histamine, acetylcholine.
  • NSAIDs/Aspirin: Inhibit COX-1 → ↓ prostaglandin synthesis → ↓ mucus and bicarbonate secretion, direct mucosal injury.
  • Pepsin: Proteolytic enzyme activated at low pH.
  • Bile reflux: Particularly in gastric ulcers.
  • Smoking: ↓ prostaglandins, ↓ bicarbonate, ↑ gastric acid.
Defensive Factors (↓ in ulcer):
  • Mucus-bicarbonate layer: Forms gel barrier trapping bicarbonate.
  • Surface epithelial cells: Tight junctions prevent acid back-diffusion; rapid renewal.
  • Prostaglandins (PGE2, PGI2): Stimulate mucus and bicarbonate, increase blood flow, promote cell renewal.
  • Mucosal blood flow: Removes excess acid and delivers nutrients.
  • Alkaline tide: Neutralizes residual acid.
Clinical Features: Epigastric pain (duodenal: relieved by food; gastric: worsened by food), nausea, heartburn. Complications: bleeding, perforation, obstruction, malignant transformation.
Management:
Medical (first-line):
  • Eradicate H. pylori (Triple therapy): PPI (Omeprazole) + Amoxicillin + Clarithromycin for 14 days.
  • Proton Pump Inhibitors (PPIs): Omeprazole, Pantoprazole - most effective acid suppressants (block H+/K+-ATPase pump).
  • H2 receptor blockers: Ranitidine, Famotidine.
  • Antacids: Symptomatic relief (Mg(OH)2, Al(OH)3).
  • Cytoprotective agents: Sucralfate (forms gel at ulcer base), Misoprostol (PGE1 analog).
Surgical (for complications or refractory ulcers):
  • Perforation: Emergency oversewing or patch repair.
  • Bleeding: Endoscopic hemostasis; if fails - surgery.
  • Vagotomy + drainage for refractory cases.

SHORT ESSAY - 5 marks each (Q11-17)

Q11. Enumerate the steps of phagocytosis.

Phagocytosis is the process by which phagocytes (neutrophils, macrophages) engulf and destroy microbes and debris.
Steps:
1. Chemotaxis:
  • Phagocytes are attracted to the site of infection by chemical signals (chemokines, complement C5a, bacterial products, LTB4).
2. Recognition and Attachment:
  • Phagocyte receptors bind to particles directly or via opsonins (IgG antibody, C3b complement).
  • Receptors include: Fc receptors (for IgG), complement receptors (CR1, CR3), mannose receptors, scavenger receptors.
  • Opsonization greatly enhances phagocytosis.
3. Engulfment (Endocytosis):
  • Pseudopods extend around the particle ("zipper" mechanism).
  • Plasma membrane folds around and encloses the particle in a membrane-bound vesicle called a phagosome.
4. Phagosome-Lysosome Fusion:
  • The phagosome fuses with lysosomes to form a phagolysosome.
  • Lysosomal enzymes (acid hydrolases, lysozyme, myeloperoxidase, defensins) are released into the phagolysosome.
5. Killing and Digestion:
Oxygen-dependent killing (Respiratory burst):
  • NADPH oxidase converts O2 → superoxide (O2−) → hydrogen peroxide (H2O2).
  • Myeloperoxidase converts H2O2 + Cl− → HOCl (hypochlorous acid) - most potent microbicidal agent.
  • ROS (reactive oxygen species) damage microbial DNA, proteins, lipids.
Oxygen-independent killing:
  • Lysozyme: Cleaves bacterial cell wall peptidoglycan.
  • Defensins: Disrupt microbial membranes.
  • Lactoferrin: Sequesters iron (essential for bacterial growth).
  • Acid pH of phagolysosome.
6. Elimination:
  • Debris is expelled by exocytosis (degranulation) or phagocyte undergoes apoptosis.
(Robbins Pathology: "Phagocytosis involves: recognition/attachment, engulfment, killing and degradation")

Q12. Describe the factors regulating cardiac output.

Cardiac Output (CO) = Heart Rate (HR) × Stroke Volume (SV)
  • Normal CO = ~5 L/min (HR 72/min × SV 70 mL)
Factors Regulating HEART RATE:
FactorEffect
Sympathetic (β1 receptors, noradrenaline)↑ HR (positive chronotropy)
Parasympathetic (vagus nerve, acetylcholine)↓ HR (negative chronotropy)
Temperature↑ temperature → ↑ HR
Thyroid hormone↑ HR
Hypoxia / CO2↑ HR via chemoreceptors
Bainbridge reflex↑ venous return → ↑ HR
Factors Regulating STROKE VOLUME:
1. Preload (end-diastolic volume):
  • Frank-Starling Law: As venous return increases → EDV increases → greater fiber stretch → greater force of contraction → ↑ SV.
  • Factors increasing preload: ↑ venous return, ↑ blood volume, venoconstriction.
2. Afterload (aortic pressure / peripheral resistance):
  • ↑ afterload → ↓ SV (heart works harder to eject blood).
  • Factors: hypertension, aortic stenosis.
3. Contractility (Inotropy):
  • Intrinsic strength of contraction independent of preload.
  • Increased by: sympathetic stimulation, catecholamines, digitalis, ↑ Ca²+, thyroid hormone.
  • Decreased by: heart failure, hypoxia, acidosis, β-blockers.
Local Regulation:
  • Metabolic autoregulation: ↑ tissue demand → local vasodilation → ↑ venous return → ↑ CO.
  • Anemia, AV fistula: ↑ CO to compensate.

Q13. Define GFR. Mention its normal value. Explain the factors regulating it.

Definition: GFR (Glomerular Filtration Rate) is the volume of filtrate formed by both kidneys per minute through the glomerular capillaries into Bowman's capsule.
Normal Value: 125 mL/min (180 L/day) in adults. In clinical practice, GFR is expressed as mL/min/1.73 m².
Filtration Fraction: GFR/RPF = 125/625 = 0.2 (20% of renal plasma is filtered).
Factors Regulating GFR:
1. Starling Forces (Glomerular Ultrafiltration Pressure):
  • GFR is determined by the net filtration pressure (NFP):
    • NFP = Glomerular hydrostatic pressure (PGC, ~60 mmHg) - Bowman's capsule pressure (PBS, ~15 mmHg) - Oncotic pressure of plasma (πGC, ~32 mmHg)
    • NFP = 60 - 15 - 32 = +13 mmHg
2. Renal Autoregulation (70-180 mmHg MAP):
  • Myogenic mechanism: Increased arterial pressure → afferent arteriole constricts (prevents rise in PGC).
  • Tubuloglomerular feedback (TGF): ↑ NaCl delivery to macula densa → adenosine release → afferent arteriole constriction → ↓ GFR (negative feedback).
3. Afferent Arteriole Tone:
  • Dilation (prostaglandins, NO, dopamine) → ↑ PGC → ↑ GFR.
  • Constriction (noradrenaline, angiotensin II, endothelin) → ↓ PGC → ↓ GFR.
4. Efferent Arteriole Tone:
  • Constriction (angiotensin II mildly) → ↑ PGC → ↑ GFR (but severe constriction → ↓ GFR).
5. Plasma Oncotic Pressure:
  • ↑ Protein (dehydration, infusion) → ↑ πGC → ↓ GFR.
  • ↓ Protein (nephrotic syndrome, malnutrition) → ↓ πGC → ↑ GFR.
6. Filtration Coefficient (Kf):
  • Determined by glomerular capillary permeability and surface area.
  • ↑ Kf (glomerulonephritis, mesangial relaxation) → ↑ GFR.

Q14. Describe the chemical regulation of respiration.

Chemical regulation of respiration maintains constant PaO2, PaCO2, and pH through central and peripheral chemoreceptors.
Central Chemoreceptors:
  • Located in the ventral surface of medulla oblongata (separate from respiratory centers).
  • Sensitive to ↑ PaCO2 (hypercapnia) and ↓ pH of CSF.
  • Mechanism: CO2 crosses the blood-brain barrier → combines with H2O → H2CO3 → H+ + HCO3−. H+ ions stimulate chemoreceptors → ↑ ventilation.
  • CO2 is the most important chemical regulator of respiration in normal conditions.
  • Do NOT respond directly to O2 levels.
Peripheral Chemoreceptors:
  • Located in carotid bodies (at bifurcation of common carotid artery - most important) and aortic bodies (in aortic arch).
  • Sensitive to: ↓ PaO2 (<60 mmHg), ↑ PaCO2, ↓ pH.
  • Carotid bodies also respond to ↓ arterial blood flow, ↑ temperature.
  • Signal via CN IX (Hering's nerve → glossopharyngeal) from carotid bodies and CN X (vagus) from aortic bodies.
Integrated Chemical Control:
StimulusReceptorResponse
↑ CO2 (PaCO2 >40 mmHg)Central >> Peripheral↑ Rate and depth of breathing
↓ pH (metabolic acidosis)Central + Peripheral↑ Ventilation (compensatory)
↓ O2 (PaO2 <60 mmHg)Peripheral only↑ Ventilation ("hypoxic drive")
Hypercapnia is the primary driver of respiration in healthy individuals. In chronic lung disease patients retaining CO2, the hypoxic drive from peripheral chemoreceptors becomes the predominant stimulus (reason why high-flow O2 can suppress respiration in COPD).

Q15. Describe composition and functions of Pancreatic juice.

Pancreatic Juice - Overview:
  • Volume: 1.5-2 L/day
  • pH: 8.0-8.3 (alkaline)
  • Produced by acinar cells (enzymes) and ductal cells (bicarbonate/water)
Composition:
A. Inorganic Constituents:
  • Water: Major component
  • Bicarbonate (HCO3−): Major anion; secreted in high concentrations (up to 140 mEq/L) by ductal cells in response to secretin; neutralizes gastric acid in duodenum.
  • Electrolytes: Na+, K+, Cl−
B. Organic Constituents (Enzymes):
Proteolytic enzymes (secreted as inactive zymogens):
  • Trypsinogen → Trypsin (activated by enterokinase/enteropeptidase from duodenum)
  • Chymotrypsinogen → Chymotrypsin (activated by trypsin)
  • Proelastase → Elastase
  • Procarboxypeptidase → Carboxypeptidase (cleaves C-terminal amino acids)
  • Trypsin inhibitor (prevents autodigestion within pancreas)
Lipolytic enzymes:
  • Pancreatic lipase: Hydrolyzes triglycerides → monoglycerides + fatty acids (requires co-lipase)
  • Cholesterol esterase (CECE): Hydrolyzes cholesterol esters
  • Phospholipase A2: Cleaves phospholipids
Amylolytic enzyme:
  • Pancreatic α-amylase: Hydrolyzes starch → maltose, maltotriose, limit dextrins (secreted in active form)
Other:
  • Ribonuclease (RNase) and DNase: Digest nucleic acids
Functions of Pancreatic Juice:
  1. Neutralizes gastric acid → creates optimal pH (7-8) for intestinal enzymes.
  2. Protein digestion: Endopeptidases (trypsin, chymotrypsin) cleave interior peptide bonds; exopeptidases (carboxypeptidase) cleave terminal amino acids.
  3. Fat digestion: Lipase and colipase hydrolyze triglycerides; bile salts emulsify fats first.
  4. Carbohydrate digestion: Amylase completes starch digestion begun in the mouth.
  5. Nucleic acid digestion: DNase and RNase.

Q16. Describe micturition reflex. What is cystometrogram?

Micturition Reflex:
Micturition (voiding) involves involuntary and voluntary components controlled by:
  • Spinal micturition center: Sacral segments S2-S4 (detrusor nucleus / Onuf's nucleus)
  • Higher centers: Pontine micturition center (PMC), hypothalamus, cortex (voluntary control)
Steps of Micturition Reflex:
  1. Bladder filling: Urine accumulates; detrusor muscle remains relaxed (low pressure) due to sympathetic tone (β3 adrenoceptors). Internal urethral sphincter is closed (α1 sympathetic). External sphincter is closed (somatic, pudendal nerve).
  2. Stretch stimulus: At ~300-400 mL, stretch receptors in the bladder wall send afferent impulses via pelvic nerve → S2-S4.
  3. Micturition reflex arc:
    • Afferent: Pelvic nerve (sensory) from detrusor stretch receptors.
    • Integration: Sacral micturition center (S2-S4) coordinates with pontine micturition center.
    • Efferent:
      • Parasympathetic (pelvic nerve): Contracts detrusor (M3 receptors).
      • Sympathetic inhibited: Internal sphincter opens.
      • Somatic (pudendal nerve) inhibited: External sphincter relaxes (voluntary override can maintain contraction).
  4. Voiding: Detrusor contracts, both sphincters relax → urine expelled.
  5. After micturition: Sympathetic tone restores sphincter closure; detrusor relaxes; cycle restarts.
Cystometrogram (CMG): A cystometrogram is a graphical recording of intravesical (bladder) pressure vs. volume during bladder filling and voiding.
Phases on the CMG:
  • Phase I (Filling / Tonus limb): Slight rise in pressure as bladder fills (0-300 mL). Bladder compliance is high (pressure remains nearly flat due to plastic nature of smooth muscle).
  • First sensation to void: ~150-200 mL
  • Phase II: Micturition contractions appear as pressure waves when the micturition reflex is triggered.
  • Phase III (Voiding): Sharp rise in pressure during detrusor contraction, pressure falls after voiding.
Normal intravesical pressure during filling: 5-15 cmH2O Maximum cystometric capacity: ~400-500 mL
Clinical use: Diagnoses neurogenic bladder, overactive bladder, urethral obstruction, incontinence.

Q17. Enumerate the duties of a doctor.

A doctor's duties encompass professional, ethical, and social responsibilities:
1. Duties Toward Patients:
  • Provide competent medical care with compassion and respect for patient dignity.
  • Maintain patient confidentiality (except where law requires disclosure).
  • Obtain informed consent before any examination, investigation, or treatment.
  • Provide emergency care when needed, regardless of payment.
  • Not refuse treatment on grounds of race, religion, gender, or social status.
  • Maintain continuity of care; not abandon a patient midway without notice.
  • Refer to appropriate specialists when necessary.
  • Truthfully inform patients about their condition and treatment options.
2. Duties Toward the Medical Profession:
  • Maintain the dignity and honour of the profession.
  • Not indulge in self-advertisement or canvassing.
  • Not poach patients from colleagues.
  • Maintain proper medical records.
  • Cooperate with medicolegal requirements and report notifiable diseases.
  • Continue medical education (CME) to stay updated.
3. Duties Toward Society:
  • Report communicable/notifiable diseases to public health authorities (e.g., cholera, plague, TB).
  • Participate in health promotion and disease prevention.
  • Provide impartial medicolegal services when required.
  • Report cases of suspected child abuse, unnatural death, or injury due to crime.
  • Respect the law and not prescribe controlled substances irresponsibly.
4. Duties Toward the State:
  • Provide evidence in courts when summoned.
  • Issue certificates (death, fitness, medical) honestly and accurately.
  • Participate in national health programs.
5. Duty to Themselves:
  • Maintain physical and mental health.
  • Practice self-regulation and avoid substance abuse.
  • Seek help if suffering from a condition that may impair professional duties.
According to MCI (NMC) Code of Ethics: A registered medical practitioner shall maintain the highest moral and ethical standards and shall always act in the best interest of the patient.

Study tip: For the exam on 14/07/2025, prioritize Q1 (long essay - 10 marks), then Q10 (peptic ulcer), Q8 (shock), and Q9 (hypoxia) as they are high-yield topics. Make sure to draw labeled diagrams for ECG, O2-Hb dissociation curve, and micturition reflex wherever applicable - the paper specifically mentions diagrams earn marks.
This is a shared conversation. Sign in to Orris to start your own chat.